Hair & Scalp

Hair loss is usually noticed as an absence: more scalp becomes visible, the hairline moves backward, the part becomes wider or the density no longer looks the way it once did. Clinically, however, hair loss is not one process. The visible hair is the final product of a follicle whose growth cycle, calibre and survival can be influenced by genetics, hormones, inflammation, systemic illness, medication and the condition of the scalp around it.

This is why I would not start a hair consultation by counting how many grafts can be transplanted. A receding male hairline, diffuse shedding after illness, female-pattern thinning, alopecia areata and a scarring inflammatory alopecia can all make the scalp more visible, but they are biologically different problems. Transplanting follicles into the wrong diagnosis does not make the diagnosis disappear. In some conditions it can simply move surgery ahead of treatment that should have come first.

The first question is therefore not “How much hair can we add?” It is “Why is hair being lost, which follicles are still capable of producing useful hair, and is the process stable enough that redistribution makes sense?”

Hair density is more than the number of follicles

Visible density depends on follicle number, but also on hair-shaft calibre, colour contrast with the scalp, curl, length and the angle at which hairs emerge. A person with relatively coarse, wavy hair can appear much denser than someone with the same number of follicles producing fine straight shafts. This is why two patients with similar degrees of follicular loss can require very different transplant strategies.

Miniaturisation adds another layer. In androgenetic hair loss, genetically susceptible follicles can progressively produce thinner and shorter hairs before becoming cosmetically insignificant. The follicle has not necessarily disappeared simply because the scalp looks empty. Part of the visible loss can come from reduced calibre rather than complete absence.

This distinction matters because medical treatment and transplantation solve different problems. A transplant redistributes selected follicles from one region to another. It does not prevent every susceptible native follicle around them from continuing to miniaturise.

Hair transplantation does not create a new supply of follicles. It redistributes a limited existing supply.

The pattern of loss often tells us more than the amount of loss

Androgenetic alopecia typically follows recognisable patterns, although the pattern differs between individuals and between men and women. In men, recession can involve the frontal hairline and temples before or alongside crown thinning. In women, the central part and frontal density may become progressively reduced while the frontal edge can remain relatively preserved.

Diffuse shedding is different. Telogen effluvium can produce a relatively sudden increase in shedding after physiological stressors such as illness, major surgery, rapid weight change or other systemic events. The patient can feel that enormous amounts of hair are being lost without showing the same patterned miniaturisation seen in androgenetic alopecia.

Patchy loss belongs to another category again. Alopecia areata, traction, infection and scarring disorders can create focal defects for completely different reasons. Calling all of these “hair thinning” removes the information needed to decide what should happen next.

Active shedding and permanent pattern loss should not automatically receive the same treatment

A patient who notices increased hair in the shower can understandably assume that transplantation is the definitive solution. But if the loss represents a temporary shift in the growth cycle, surgery may be irrelevant. The more useful intervention is identifying and addressing the trigger while allowing the follicles to cycle again.

At the opposite extreme, a patient with gradually progressive patterned miniaturisation may have a long-term process that requires a strategy for both current appearance and future loss. If surgery is planned as though the pattern has already finished, transplanted hair can remain while native hair behind it continues to thin, creating a new discontinuity several years later.

I therefore care about time. How quickly did the change occur? Has the pattern progressed for years or appeared over months? Is shedding still active? The timeline is part of the diagnosis.

Scalp health matters because a follicle does not exist independently from the tissue around it

The scalp can develop seborrhoeic dermatitis, psoriasis, folliculitis, infection, inflammatory disorders and scarring alopecias. These conditions can cause symptoms such as itching, scale, redness, pain or pustules, but some important inflammatory hair disorders can initially appear mainly as progressive thinning.

This is particularly important before transplantation. Implanting grafts into an actively inflamed or scarring scalp can produce poor survival and can fail to address the disease that continues damaging follicles. When history or examination raises that possibility, dermatological assessment and disease control come before elective restoration.

A healthy-looking scalp is therefore not simply a better canvas cosmetically. It is part of establishing that transplanted follicles are being placed into a biologically reasonable environment.

The donor area is the true limiting resource in hair transplantation

Most conventional hair transplantation relies on follicles from the occipital and selected lateral scalp where hairs are generally more resistant to androgen-related miniaturisation. That donor supply is finite. Once follicles are removed, they do not regenerate in the donor site.

This is why graft count should not become a competition. Removing very large numbers can create visible donor thinning, particularly in patients whose baseline density is limited or whose hair characteristics provide poor camouflage. An impressive recipient-area number is not a good result if it produces another aesthetic problem at the back of the head.

I think of donor hair as a lifetime resource. The question is not how many grafts can be extracted today. It is how they should be allocated if the patient may continue losing hair over the next ten or twenty years.

A hairline should be planned for the face it belongs to and the age it will continue to reach

A low straight juvenile hairline can look appealing in a young reference photograph. It can also consume a large proportion of donor supply and look increasingly artificial as the patient ages or as loss progresses behind it.

Hairline planning therefore involves height, recession at the temples, irregularity, density gradient and the relationship with forehead and facial proportions. Natural hairlines are not drawn with one perfectly straight dense edge. They contain transitional hairs and subtle asymmetry.

I prefer a hairline capable of ageing with the patient. A few millimetres of extra conservatism can preserve donor grafts, reduce the amount of surgery required and produce an appearance that remains believable decades later.

Temporal recession is not corrected simply by drawing the hairline farther forward

The frontotemporal region contributes strongly to how masculine, feminine, mature or juvenile a hairline appears. But recreating the temples requires more than filling a triangular empty area. Hair direction becomes increasingly acute laterally, and the density and calibre pattern differ from the central frontal scalp.

Improperly angled or overly coarse grafts in this region can look obvious because the temple normally contains relatively delicate hair emerging almost parallel to the skin. The shape also needs to relate to the patient’s forehead and expected future pattern of loss.

This is one of the regions where adding fewer carefully oriented follicles can be more valuable than maximising density indiscriminately.

FUE and FUT are donor-harvesting strategies, not guarantees of a particular result

Follicular unit extraction removes individual follicular units from the donor region through small circular openings. Strip harvesting removes a segment of donor scalp from which follicular units are dissected, leaving a linear donor scar. Both methods can produce high-quality grafts when performed appropriately.

The choice affects donor management and scar pattern, but neither method determines the final aesthetic result by itself. Hairline design, follicle handling, graft orientation, distribution, surgical planning and the biology of the patient matter enormously.

I therefore would not choose a transplant purely because a technique has a more marketable acronym. The harvesting method should serve the overall donor and recipient plan rather than become the plan itself.

A transplant relocates hair; it does not cure androgenetic alopecia

Transplanted follicles taken from resistant donor areas generally retain much of their donor behaviour after relocation. Native follicles surrounding them, however, remain biologically susceptible to the process that was already affecting them.

This creates an important long-term issue. A dense transplanted frontal line can remain while untreated native hair behind it becomes progressively thinner. The result can require additional surgery later simply to restore continuity.

Medical management can therefore have an important role in selected patients with androgenetic hair loss. The specific treatment depends on sex, age, medical context and contraindications. Surgery and medical treatment should be viewed as different parts of one long-term strategy rather than as competing products.

PRP and regenerative language should be kept within their actual evidence

Platelet-rich plasma has evidence supporting improvement in selected androgenetic alopecia outcomes, particularly hair density and calibre in some patients. It does not recreate follicles that no longer exist, and results vary according to preparation, protocol and individual biology.

This is where language matters. Growth factors are biological signals; they are not evidence that dormant or absent follicles have been permanently regenerated. Likewise, commercially described stem-cell, exosome or regenerative treatments should not borrow the credibility of transplantation or established medical treatment simply because they are performed on the scalp.

A biologically interesting mechanism is not the same as a predictable clinical endpoint. I would rather promise less and know what problem the treatment is actually expected to influence.

Female hair loss needs its own assessment rather than a smaller version of male transplantation

Women frequently present with diffuse thinning, widening of the central part or reduced density behind the frontal hairline. Donor density can also be affected, which changes how useful transplantation may be. Hormonal and medical causes may require investigation according to the history.

This means that a female patient with reduced density is not automatically a transplant candidate simply because a male patient with the same visible amount of scalp would be. The donor area has to be genuinely capable of supplying stronger follicles than the recipient region.

When the entire scalp is diffusely miniaturised, moving follicles from one thinning area to another may offer limited value. Diagnosis is therefore especially important before discussing graft numbers.

Hair loss after pregnancy, illness or major weight change needs time before irreversible decisions

Physiological stress can shift a larger number of follicles into the resting phase, producing noticeable shedding months after the original event. Postpartum shedding is one common example. Major illness, surgery and rapid weight loss can produce similar patterns.

This can be extremely distressing because the amount shed can be dramatic. But surgery performed while the process is still evolving risks treating a temporary density change as though it were permanent absence.

I prefer to understand the timeline, stabilise relevant triggers and observe recovery where appropriate before deciding that transplantation is needed. Waiting is sometimes part of diagnosis rather than an absence of treatment.

Previous transplantation can create new problems that are not solved by adding more grafts

A patient can have a hairline that is too low, unnaturally straight, poorly angled or constructed with grafts that are too coarse for the frontal edge. Donor over-harvesting can also create visible thinning or a moth-eaten appearance at the back and sides.

Revision therefore begins with deciding which problem dominates. Additional grafts can soften a poor hairline in some cases. Graft removal or redistribution may be required in others. Scalp micropigmentation can sometimes help donor visibility. If the donor supply has already been depleted, the remaining options become more limited.

This is why responsible first-time planning is so important. Donor follicles used poorly today cannot simply be replaced from an unlimited reserve tomorrow.

Hair transplantation is judged months later, not when grafts are visible after surgery

Transplanted hairs can shed after the procedure while the follicles remain in place and later enter new growth. Growth emerges gradually and maturation continues over many months. Density therefore cannot be judged from the early postoperative appearance.

Native hair can also experience temporary postoperative shedding. The patient needs to understand these timelines so that normal biological phases are not interpreted immediately as graft failure.

The important result is not how densely grafts appear to be packed on the day of surgery. It is how naturally the surviving follicles grow, orient and integrate once the scalp has passed through the full growth cycle.

How I assess Hair & Scalp begins with diagnosis before design

I look at the pattern and distribution of loss, calibre variation and scalp condition before discussing hairline shape. Donor density and miniaturisation are examined separately because transplantation requires a region capable of providing useful long-term follicles.

The history matters: onset, progression, shedding, family pattern, relevant illnesses, medication, pregnancy, weight change and previous treatment. Symptoms such as itching, pain, scale or rapid focal loss can change the assessment substantially.

Only after that do we discuss restoration. For one patient the useful plan may be medical management and observation. Another may be a good transplant candidate. Another needs dermatological investigation. The ability to implant a graft does not mean that transplantation is the correct first treatment for every visible scalp.

The endpoint should be the appearance of hair, not the appearance of transplantation

A natural result depends on density distribution, direction, irregularity and long-term planning. The frontal edge should not look stamped onto the forehead. The donor should not reveal where thousands of grafts were removed. And the plan should anticipate enough future change that the transplanted region continues to make sense if native hair evolves.

I do not think the best transplant is the one that moves the most follicles in one session. It is the one that spends a finite donor resource where it produces the greatest long-term visual value.

Sometimes that means a more conservative hairline, lower density in one region or postponing surgery while the diagnosis or progression becomes clearer. Restraint is not lost opportunity when it preserves future options.

I do not treat an empty area of scalp. I treat the biology of hair loss, then decide whether redistribution of a finite donor supply is coherent.

When does a Hair & Scalp consultation make sense?

Consultation is useful for gradual patterned loss, receding hairline, crown thinning, widening part, persistent diffuse reduction or dissatisfaction after previous transplantation. It is equally useful when the patient does not know whether the loss is permanent or temporary.

Rapid patchy loss, scalp inflammation, pain, significant scaling or suspected scarring deserves diagnostic attention before elective transplantation. In those situations, identifying the disease is more important than filling the visible space.

The useful consultation should leave you knowing what type of loss is suspected, whether the donor area is adequate, what may continue to change and whether surgery, medical treatment, observation or another specialty is the appropriate next step.

Frequently asked questions

Does a hair transplant create new hair follicles?

No. It relocates existing follicles from donor regions to areas where greater density or a reconstructed hairline is desired. The donor supply is finite, which is why long-term allocation matters.

Will transplanted hair fall out again?

Appropriately selected donor follicles are generally more resistant to androgenetic miniaturisation, but native hair around them can continue to thin. A transplant therefore does not cure the underlying pattern of hair loss.

How many grafts do I need?

There is no meaningful universal number. The requirement depends on recipient area, desired density, hair calibre, donor availability, future loss and hairline design. The maximum number removable should not automatically become the number transplanted.

Is FUE better than FUT?

Neither harvesting method is universally superior. They produce different donor scar patterns and can suit different donor-management situations. Final aesthetic quality also depends heavily on planning, graft handling, orientation and recipient design.

Can PRP replace a hair transplant?

No. PRP may improve selected androgenetic hair-loss parameters in some patients, but it does not redistribute follicles into a genuinely bald region. The two treatments have different mechanisms and indications.

Can women have hair transplantation?

Yes, but candidacy depends strongly on the pattern and donor area. Diffuse thinning can affect donor follicles as well as recipient areas, making diagnosis particularly important.

Should I have a transplant while I am actively losing hair?

It depends on the diagnosis and expected progression. In rapidly evolving loss, stabilisation or further assessment may be more appropriate before committing donor follicles to a permanent design.

When would you recommend no hair transplant?

I would avoid transplantation when the diagnosis is unclear, an inflammatory or scarring process is active, donor capacity is inadequate, the expected future pattern makes the proposed design unsustainable or the requested hairline would consume donor resources disproportionately.